| Reaction Details |
|---|
 | Report a problem with these data |
| Target | C-X-C chemokine receptor type 3 |
|---|
| Ligand | BDBM50225724 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | ChEMBL_458685 (CHEMBL942022) |
|---|
| Ki | 260±n/a nM |
|---|
| Citation |  Watson, RJ; Allen, DR; Birch, HL; Chapman, GA; Hannah, DR; Knight, RL; Meissner, JW; Owen, DA; Thomas, EJ Development of CXCR3 antagonists. Part 2: Identification of 2-amino(4-piperidinyl)azoles as potent CXCR3 antagonists. Bioorg Med Chem Lett17:6806-10 (2007) [PubMed] Article |
|---|
| More Info.: | Get all data from this article, Assay Method |
|---|
| |
| C-X-C chemokine receptor type 3 |
|---|
| Name: | C-X-C chemokine receptor type 3 |
|---|
| Synonyms: | AAO92295.1 | C-X-C chemokine receptor type 3 | C-X-C chemokine receptor type 3 (CXCR3) | C-X-C chemokine receptor type 3 (CXCR3A) | CXCR3 | CXCR3A | CXCR3_HUMAN | GPR9 | chemokine (C-X-C motif) receptor 3 |
|---|
| Type: | Enzyme Catalytic Domain |
|---|
| Mol. Mass.: | 40665.65 |
|---|
| Organism: | Homo sapiens (Human) |
|---|
| Description: | n/a |
|---|
| Residue: | 368 |
|---|
| Sequence: | MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALY
SLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFG
SGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCL
LFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILA
VLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAK
SVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSET
SEASYSGL
|
|
|
|---|
| BDBM50225724 |
|---|
| n/a |
|---|
| Name | BDBM50225724 |
|---|
| Synonyms: | CHEMBL250658 | N-(4-(3,5-bis(trifluoromethyl)phenyl)thiazol-2-yl)-1-(((1R,5S)-6,6-dimethylbicyclo[3.1.1]hept-2-en-2-yl)methyl)piperidin-4-amine |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C26H29F6N3S |
|---|
| Mol. Mass. | 529.584 |
|---|
| SMILES | CC1(C)[C@@H]2C[C@H]1C(CN1CCC(CC1)Nc1nc(cs1)-c1cc(cc(c1)C(F)(F)F)C(F)(F)F)=CC2 |c:37| |
|---|
| Structure | 
|
|---|
Search and Browse
